companies

Terapet

Founded 2019
Employees 5+
Primary contact
Rue du Pré-Bouvier 7
Meyrin
1217 Geneva
Switzerland
+41 76 466 9139
Links
https://terapet.ch/
Diseases & Conditions
Sections
Terapet has developed an add-on device to improve existing proton therapy, which is an advanced form of radiotherapy for cancer treatment that can target tumors with extreme precision. It is a non-invasive medical device placed close to the patient during the treatment to enable doctors to monitor the delivered proton dose inside the patients during cancer treatment: in-vivo, non-invasively, in 3D and in real-time. As a result, the doctor is able to remove the margins around the tumor, which means a safer and more precise treatment for the patient.
Select partners: CERN, Karolinska Institute, Skandion Clinic, Politecnico di Milano.
Founded 2019
Employees 5+
Primary contact
Rue du Pré-Bouvier 7
Meyrin
1217 Geneva
Switzerland
+41 76 466 9139
Links
https://terapet.ch/
Diseases & Conditions
Sections

Funding 💰

Total $3.1M
Select investors Venture Kick, Nina Capital, Foundation for Technological Innovation (FIT), MassChallenge, Fongit Seed Invest, InnoSuisse, Efficient Frontier Investing

Key people 🧑‍🤝‍🧑

Highlights ⭐

  • Solving a problem: Today, there are no commercial solutions for verifying, in-vivo, that the treated patient receives the correct dose of proton therapy at the right location.
  • Bold vision: Terapet aims to have its solutions an integral part of the next generation of proton therapy, which will be safer, more precise, faster and available for the wider public.
  • It's tested: Terapet tested its device with real proton beams at Skandion Clinic in Sweden in April 2021. At that time, they managed to detect the proton beams in-vivo with < 1 mm precision, as expected.
  • Science-backed team: Two of the co-founders are former CERN physicists with more than 10 years of experience from CERN, which has long been involved in the development of proton therapy.

Video ▶️

Awards & Recognitions 🏆

  • 2021 Among Bilan's Top 50 startups to invest in 🔗
  • 2020 One of 10 Venture Finalists within Health & Nutrition vertical 🔗
  • 2019 Swiss Innovation Challenge: Finalist 🔗
  • 2019 MassChallenge Top 100 Swiss Startups: Finalist 🔗
Last update: August 22, 2022